Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects

Journal of Cell Biology

Volumn 137, Issue 7, 1997, Pages 1627-1638

  Vandevoorde, Veronique ^a   Haegeman, Guy ^a   Fiers, Walter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL KILLING; CELL MEMBRANE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

DIMERIZATION; HUMANS; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0030990123     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.137.7.1627     Document Type: Article

References (66)

1. Adam, D., U. Keßler, and M. Krönke. 1995. Cross-linking of the p55 tumor necrosis factor receptor cytoplasmic domain by a dimeric ligand induces nuclear faclor-κB and mediates cell death. J Biol. Chem. 270:17482-17487.
2. Adam, D., S. Adam-Klages, and M. Krönke. 1996a. Identification of p55 tumor necrosis factor receptor associated proteins that couple to signaling pathways not initiated by the death domain. J. Inflamm. 47:61-66.
3. Adam, D., K. Wiegmann, S. Adam-Klages, A. Ruff, and M. Krönke. 1996b. A novel cytoplasmic domain of the p55 TNF receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271:14617-14622.
4. Adam-Klages, S., D. Adam, K. Wiegmann, S. Struve, W. Kolanus, J. Schneider-Mergener, and M. Krönke. 1996. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 86:937-947.
5. Aggarwal, B.B., and K. Nalarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93-124.
6. Banner, D.W., A. D'Arcy, W. Janes, R. Gentz, H.-J. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kD TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell. 73:431-445.
7. Bazzoni, F., and B. Beutler. 1995. How do tumor necrosis factor receptors work? J. Inflamm. 45:221-238.
8. Bazzoni, F., E. Alejos, and B. Beutler. 1995. Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc. Natl. Acatl. Sci. USA. 92: 5376-5380.
9. Belka, C., K. Wiegmann, D. Adam, R. Holland, M. Neuloh, F. Herrmann, M. Krönke, and M.A. Brach. 1995. Tumor necrosis factor (TNF)-α activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO (Eur. Mol. Biol. Organ.) J. 14:1156-1165.
10. Beyaert, R., B. Vanhaesebroeck, P. Suffys, F. Van Roy, and W. Fiers. 1989. Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 86:9494-9498.
11. Beyaert, R., A. Cuenda, W. Vanden Berghe, S. Plaisance, J.C. Lee, G. Haegeman, P. Cohen, and W. Fiers. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor. EMBO (Eur. Mol. Biol. Organ.) J. 15:1914-1923.
12. Boldin, M.P., I.L. Mett, E.E. Varfolomeev, I. Chumakov, Y. Shemer-Avni, J.H. Camonis, and D. Wallach. 1995a. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270:387-391.
13. Boldin, M.P., I.L. Mett, and D. Wallach. 1995b. A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its "death domain." FEBS (Fed. Eur. Biol. Soc.) Lett. 367:39-44.
14. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:803-815.
15. Boshart, M., M. Klüppel, A. Schmidt, G. Schütz, and B. Luckow. 1992. Reporter constructs with low background activity utilizing the cat gene. Gene. 110:129-130.
16. Brakebusch, C., Y. Nophar, O. Kemper, H. Engelmann, and D. Wallach. 1992. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO (Eur. Mol. Biol. Organ.) J. 11:943-950.
17. Brockhaus, M., H.-J. Schoenfeld, E.-J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 87:3127-3131.
18. Carswell, E.A., L.J. Old, R.L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA. 72:3666-3670.
19. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
20. Chinnaiyan, A.M., C.G. Tepper, M.F. Seldin, K. O'Rourke, F.C. Kischkel, S. Hellbardt, P.H. Krammer, M.E. Peter, and V.M. Dixit. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
21. Darnay, B.G., S.A.G. Reddy, and B.B. Aggarwal. 1994. Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J. Biol. Chem. 269:20299-20304.
22. Declercq, W., P. Vandenabeele, and W. Fiers. 1995. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain. Cytokine. 7:701-709.
23. Defilippi, P., P. Poupart, G. Haegeman, J. Tavernier, W. Fiers, and J. Content. 1987. Induction of 26 kDa protein mRNA in human cells treated with recombinant human tumour necrosis factor (rTNF-α). In The Biology of the Interferon System 1986. K. Cantell and H. Schellekens, editors. Martinus Nijhoff Publishers, Dordrecht. 217-222.
24. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 265:1531-1536.
25. Espevik, T., M. Brockhaus, H. Loetscher, U. Nonstad, and R. Shalaby. 1990. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171:415-426.
26. Fiers, W. 1995. Biologic therapy with TNF: preclinical studies. In Biologic Therapy of Cancer. 2nd Ed. V.T. DeVita, Jr., S. Hellman, and S.A. Rosenberg, editors. J.B. Lippincott, Philadelphia. 295-327.
27. Figueiredo-Pereira, M.E., K.A. Berg, and S. Wilk. 1994. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J. Neurochem. 63:1578-1581.
28. Graham, F.L., and A.J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:456-467.
29. Grooten, J., V. Goossens, B. Vanhaesebroeck, and W. Fiers. 1993. Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine. 5:546-555.
30. Hsu, H., J. Xiong, and D.V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:495-504.
31. Hsu, H., H.-B. Shu, M. G. Pan, and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299-308.
32. Hug, H., M. Costas, P. Staeheli, M. Aebi, and C. Weissmann. 1988. Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol. Cell. Biol. 8:3065-3079.
33. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932-10937.
34. Jones, E.Y., D.I. Stuart, and N.P.C. Walker. 1989. Structure of tumour necrosis factor. Nature (Lond.). 338:225-228.
35. Landegren, U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J. Immunol. Methods. 67:379-388.
36. Leslie, A.G.W. 1990. Refined crystal structure of type III chloramphenicol acetyltransferase at 1.75 Å resolution. J. Mol. Biol. 213:167-186.
37. Lleonart, R., D. Näf, H. Browning, and C. Weissmann. 1990. A novel, quantitative bioassay for type I interferon using a recombinant indicator cell line. Biotechnology (NY). 8:1263-1267.
38. Loetscher, H., Y.E. Pan, H.W. Lahm, R. Gentz, M. Brockhaus, H. Tabuchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:351-359.
39. Loetscher, H., R. Gentz, M. Zulauf, A. Lustig, H. Tabuchi, E.-J. Schlaeger, M. Brockhaus, H. Gallati, M. Manneberg, and W. Lesslauer. 1991. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNFα and TNFβ and inhibition of TNF activity. J. Biol. Chem. 266: 18324-18329.
40. Luckow, B., and G. Schütz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
41. Mertens, N., E. Remaut, and W. Fiers. 1995. Tight transcriptional control mechanism ensures stable high-level expression from T7 promoter-based expression plasmids. Biotechnology. 13:175-179.
42. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell. 85:817-827.
43. Nakamaye, K.L., and F. Eckstein. 1986. Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Res. 14:9679-9698.
44. Patestos, N.P., G. Haegeman, V. Vandevoorde, and W. Fiers. 1993. Activation of the nuclear factor κB is not sufficient for regulation of tumor necrosis factor-induced interleukin-6 gene expression. Biochimie (Paris). 75:1007-1018.
45. Pennica, D., W.J. Kohr, B.M. Fendly, S.J. Shire, H.E. Raab, P.E. Borchardt, M. Lewis, and D.V. Goeddel. 1992. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-α induced receptor aggregation. Biochemistry. 31:1134-1141.
46. Plaisance, S., W. Vanden Berghe, E. Boone, W. Fiers, and G. Haegeman. 1997. The recombination signal sequence binding protein (RBP-Jκ) is constitutively bound to the NF-κB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol. Cell. Biol. In press.
47. Rosenberg, A.M., B.N. Lade, D. Chui, S. Lin, J.J. Dunn, and F.W. Studier. 1987. Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene. 56:125-135.
48. Rothe, M., S.C. Wong, W.J. Henzel, and D.V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:681-692.
49. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:959-962.
50. Song, H.Y., J.D. Dunbar, Y.X. Zhang, D. Guo, and D.B. Donner. 1995. Identification of a protein with homology to hsp90 that binds the type-1 tumor necrosis factor receptor. J. Biol. Chem. 270:3574-3581.
51. Southern, P.J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
52. Stanger, B.Z., P. Leder, T.H. Lee, E. Kim, and B. Seed. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81:513-523.
53. Stanssens, P., C. Opsomer, Y.M. McKeown, W. Kramer, M. Zabeau, and H.-J. Fritz. 1989. Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers. Nucleic Acids Res. 17:4441-4453.
54. Suffys, P., R. Beyaert, F. Van Roy, and W. Fiers. 1987. Reduced tumour necrosis factor-induced cytotoxicity by inhibitors of the arachidonic acid metabolism. Biochem. Biophys. Res. Commun. 149:735-743.
55. Tada, H., O. Shiho, K. Kuroshima, M. Koyama, and K. Tsukamoto. 1986. An improved colorimetric assay for interleukin 2. J. Immunol. Methods. 93:157-165.
56. Tartaglia, L.A., and D.V. Goeddel. 1992. Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J. Biol. Chem. 267:4304-4307.
57. Tartaglia, L.A., T.M. Ayres, G.H.W. Wong, and D.V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:845-853.
58. Traenckner, E.B.-M, S. Wilk, and P.A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO (Eur. Mol. Biol. Organ.) J. 13: 5433-5441.
59. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5:392-399.
60. Vanden Berghe, W., G. Haegeman, and W. Fiers. 1993. Studies on the inducibility of the IL6 promoter using a reporter gene construction. Arch. Intern. Physiol. Biochim. Biophys. 101:B35.
61. Vandevoorde, V., G. Haegeman, and W. Fiers. 1991. Tumor necrosis factor-induced interleukin-6 expression and cytotoxicity follow a common signal transduction pathway in L929 cells. Biochem. Biophys. Res. Commun. 178: 993-1001.
62. Vanhaesebroeck, B., S. Van Bladel, A. Lenaerts, P. Suffys, R. Beyaert, R. Lucas, F. Van Roy, and W. Fiers. 1991. Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line. Cancer Res. 51:2469-2477.
63. Van Ostade, X., J. Tavernier, T. Prangé, and W. Fiers. 1991. Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis. EMBO (Eur. Mol. Biol. Organ.) J. 10:827-836.
64. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
65. Wiegmann, K., S. Schütze, T. Machleidt, D. Witte, and M. Krönke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1005-1015.
66. Wingfield, P., R.H. Pain, and S. Craig. 1987. Tumour necrosis factor is a compact trimer. FEBS (Fed. Eur. Biol. Soc.) Lett. 211:179-184.